Total Payments
$166,777
2024 Payments
$38,010
Companies
26
Transactions
235
Medicare Patients
730
Medicare Billing
$141,031
Payment Breakdown by Category
Consulting$120,494 (72.2%)
Travel$19,427 (11.6%)
Other$18,780 (11.3%)
Food & Beverage$7,874 (4.7%)
Education$202.06 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $120,494 | 60 | 72.2% |
| Travel and Lodging | $19,427 | 42 | 11.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $17,344 | 6 | 10.4% |
| Food and Beverage | $7,874 | 119 | 4.7% |
| Grant | $1,436 | 2 | 0.9% |
| Education | $202.06 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $40,623 | 58 | $0 (2024) |
| Merck Sharp & Dohme LLC | $40,074 | 32 | $0 (2024) |
| GlaxoSmithKline, LLC. | $17,821 | 19 | $0 (2024) |
| AstraZeneca UK Limited | $13,121 | 18 | $0 (2024) |
| Clovis Oncology, Inc. | $11,526 | 19 | $0 (2022) |
| Seagen Inc. | $8,094 | 13 | $0 (2022) |
| Eisai Inc. | $6,372 | 6 | $0 (2024) |
| Genentech USA, Inc. | $4,582 | 12 | $0 (2021) |
| TESARO, Inc. | $4,363 | 22 | $0 (2019) |
| PFIZER INC. | $4,159 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $38,010 | 29 | Merck Sharp & Dohme LLC ($19,185) |
| 2023 | $22,492 | 44 | AstraZeneca Pharmaceuticals LP ($7,077) |
| 2022 | $30,613 | 36 | Merck Sharp & Dohme LLC ($8,461) |
| 2021 | $16,918 | 12 | GlaxoSmithKline, LLC. ($3,900) |
| 2020 | $10,058 | 9 | GlaxoSmithKline, LLC. ($2,925) |
| 2019 | $20,176 | 36 | AstraZeneca Pharmaceuticals LP ($7,954) |
| 2018 | $16,953 | 42 | Merck Sharp & Dohme Corporation ($8,351) |
| 2017 | $11,557 | 27 | AstraZeneca Pharmaceuticals LP ($5,141) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $160.66 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $2,460.00 | General |
| 10/29/2024 | Eisai Inc. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,445.00 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Corcept Therapeutics | Korlym (Drug) | Consulting Fee | Cash or cash equivalent | $487.50 | General |
| Category: Endocrinology | ||||||
| 10/17/2024 | AstraZeneca UK Limited | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $60.78 | General |
| Category: Oncology | ||||||
| 10/16/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $147.05 | General |
| Category: ONCOLOGY | ||||||
| 10/16/2024 | Incyte Corporation | — | Food and Beverage | Cash or cash equivalent | $43.00 | General |
| 06/26/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,540.00 | General |
| 06/26/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 06/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $243.58 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $9,234.80 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $376.48 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $108.50 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $376.48 | General |
| Category: ONCOLOGY | ||||||
| 06/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $133.09 | General |
| Category: ONCOLOGY | ||||||
| 05/20/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| 05/07/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,200.00 | General |
| 05/03/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| 04/01/2024 | ABBVIE INC. | ELAHERE (Drug) | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,055.00 | General |
| 03/18/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $64.00 | General |
| Category: Oncology | ||||||
| 03/17/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $106.49 | General |
| 03/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $59.55 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 134 | 271 | $138,330 | $30,170 |
| 2022 | 6 | 209 | 385 | $173,377 | $41,309 |
| 2021 | 4 | 194 | 374 | $153,601 | $40,451 |
| 2020 | 5 | 193 | 348 | $131,559 | $29,102 |
Total Patients
730
Total Services
1,378
Medicare Billing
$141,031
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 86 | 217 | $115,564 | $24,315 | 21.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $16,186 | $4,005 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 25 | $6,580 | $1,849 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 98 | 232 | $119,094 | $26,727 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 36 | 36 | $19,539 | $5,068 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 55 | $13,992 | $4,112 | 29.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 16 | $9,566 | $2,430 | 25.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 35 | $7,697 | $2,030 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 11 | 11 | $3,489 | $941.43 | 27.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 86 | 197 | $97,395 | $23,534 | 24.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 51 | 51 | $26,466 | $7,679 | 29.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 44 | 91 | $22,530 | $7,176 | 31.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 35 | $7,210 | $2,063 | 28.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 80 | 159 | $75,915 | $13,755 | 18.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 49 | 94 | $22,154 | $5,786 | 26.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 33 | 33 | $16,748 | $4,365 | 26.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 48 | $9,552 | $2,860 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 12 | 14 | $7,190 | $2,336 | 32.5% |
About Dr. Shannon Westin, MD
Dr. Shannon Westin, MD is a Obstetrics & Gynecology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1740454008.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Westin, MD has received a total of $166,777 in payments from pharmaceutical and medical device companies, with $38,010 received in 2024. These payments were reported across 235 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($120,494).
As a Medicare-enrolled provider, Westin has provided services to 730 Medicare beneficiaries, totaling 1,378 services with total Medicare billing of $141,031. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Houston, TX
- Active Since 04/17/2008
- Last Updated 08/30/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1740454008
Products in Payments
- LYNPARZA (Drug) $28,768
- Rubraca (Drug) $11,532
- KEYTRUDA (Biological) $10,779
- ZEJULA (Drug) $7,917
- TIVDAK (Biological) $7,799
- Avastin (Biological) $6,572
- Lenvima (Drug) $6,372
- BAVENCIO (Drug) $4,044
- KIMMTRAK (Drug) $2,885
- ELAHERE (Drug) $2,490
- IMFINZI (Biological) $1,431
- Korlym (Drug) $487.50
- IMFINZI (Drug) $207.75
- TISSEEL (Biological) $180.76
- Elahere (Biological) $128.02
- Tivdak (Drug) $61.63
- Surgical Care - Tisseel (Biological) $27.08
- AirSeal (Device) $25.61
- VARUBI (Drug) $21.39
- MENQUADFI (Biological) $12.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Houston
Dr. George Kuhn, Md, MD
Obstetrics & Gynecology — Payments: $241,556
Obstetrics & Gynecology $241,556
Sandra Hurtado, M.d, M.D
Obstetrics & Gynecology — Payments: $160,121
Obstetrics & Gynecology $160,121
Baha Sibai, M.d, M.D
Obstetrics & Gynecology — Payments: $130,256
Obstetrics & Gynecology $130,256
Jimmy Espinoza, M.d, M.D
Obstetrics & Gynecology — Payments: $108,379
Obstetrics & Gynecology $108,379
Nicole Tran, Md, MD
Obstetrics & Gynecology — Payments: $104,647
Obstetrics & Gynecology $104,647
Dr. Daisy Ayim, Md, MD
Obstetrics & Gynecology — Payments: $102,709
Obstetrics & Gynecology $102,709